RUNX1 and myeloid neoplasm: In 1999 RUNX1 germline mutations were linked to a familial platelet disorder with associated myeloid malignancy, a rare autosomal dominant disease characterized by thrombocytopenia and a predisposition to myeloid neoplasms.